167 related articles for article (PubMed ID: 26702071)
21. A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes.
Hye Khan MA; Kolb L; Skibba M; Hartmann M; Blöcher R; Proschak E; Imig JD
Diabetologia; 2018 Oct; 61(10):2235-2246. PubMed ID: 30032428
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.
Zanchi C; Macconi D; Trionfini P; Tomasoni S; Rottoli D; Locatelli M; Rudnicki M; Vandesompele J; Mestdagh P; Remuzzi G; Benigni A; Zoja C
Diabetologia; 2017 Jun; 60(6):1114-1125. PubMed ID: 28364255
[TBL] [Abstract][Full Text] [Related]
23. Modulation of heme oxygenase-1 expression and activity affects streptozotocin-induced diabetic nephropathy in rats.
Ali MAM; Heeba GH; El-Sheikh AAK
Fundam Clin Pharmacol; 2017 Oct; 31(5):546-557. PubMed ID: 28543864
[TBL] [Abstract][Full Text] [Related]
24. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
Yuan Y; Sun H; Sun Z
Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
[TBL] [Abstract][Full Text] [Related]
25. Cocoa ameliorates renal injury in Zucker diabetic fatty rats by preventing oxidative stress, apoptosis and inactivation of autophagy.
Álvarez-Cilleros D; López-Oliva ME; Martín MÁ; Ramos S
Food Funct; 2019 Dec; 10(12):7926-7939. PubMed ID: 31773121
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic fatty rats.
Giani JF; Burghi V; Veiras LC; Tomat A; Muñoz MC; Cao G; Turyn D; Toblli JE; Dominici FP
Am J Physiol Renal Physiol; 2012 Jun; 302(12):F1606-15. PubMed ID: 22492942
[TBL] [Abstract][Full Text] [Related]
27. Long-term treatment with nebivolol attenuates renal damage in Zucker diabetic fatty rats.
Toblli JE; Cao G; Giani JF; Muñoz MC; Angerosa M; Dominici FP
J Hypertens; 2011 Aug; 29(8):1613-23. PubMed ID: 21720265
[TBL] [Abstract][Full Text] [Related]
28. 1α,25-Dihydroxyvitamin D
Wang D; Li Y; Wang N; Luo G; Wang J; Luo C; Yu W; Hao L
Am J Physiol Endocrinol Metab; 2020 Mar; 318(3):E343-E356. PubMed ID: 31891537
[TBL] [Abstract][Full Text] [Related]
29. Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome.
Luo ZF; Qi W; Feng B; Mu J; Zeng W; Guo YH; Pang Q; Ye ZL; Liu L; Yuan FH
Life Sci; 2011 Mar; 88(11-12):512-20. PubMed ID: 21241714
[TBL] [Abstract][Full Text] [Related]
30. Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis
Li X; Zhang T; Geng J; Wu Z; Xu L; Liu J; Tian J; Zhou Z; Nie J; Bai X
Antioxid Redox Signal; 2019 Sep; 31(7):521-538. PubMed ID: 31084358
[No Abstract] [Full Text] [Related]
31. Sex-differences in renal expression of selected transporters and transcription factors in lean and obese Zucker spontaneously hypertensive fatty rats.
Babelova A; Burckhardt BC; Wegner W; Burckhardt G; Henjakovic M
J Diabetes Res; 2015; 2015():483238. PubMed ID: 25710042
[TBL] [Abstract][Full Text] [Related]
32. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
[TBL] [Abstract][Full Text] [Related]
33. Potential renoprotective effects of piceatannol in ameliorating the early-stage nephropathy associated with obesity in obese Zucker rats.
Llarena M; Andrade F; Hasnaoui M; Portillo MP; Pérez-Matute P; Arbones-Mainar JM; Hijona E; Villanueva-Millán MJ; Aguirre L; Carpéné C; Aldámiz-Echevarría L
J Physiol Biochem; 2016 Sep; 72(3):555-66. PubMed ID: 26660756
[TBL] [Abstract][Full Text] [Related]
34. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway.
Zhu L; Han J; Yuan R; Xue L; Pang W
Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956
[TBL] [Abstract][Full Text] [Related]
35. High Expression of Complement Components in the Kidneys of Type 2 Diabetic Rats With Diabetic Nephropathy.
Huang Y; Xu J; Wu X; Chen X; Bai X; Zhuang Y; Fang J; Lin X
Front Endocrinol (Lausanne); 2019; 10():459. PubMed ID: 31338070
[No Abstract] [Full Text] [Related]
36. LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes.
Kelly KJ; Wu P; Patterson CE; Temm C; Dominguez JH
Am J Physiol Renal Physiol; 2008 May; 294(5):F1136-45. PubMed ID: 18322020
[TBL] [Abstract][Full Text] [Related]
37. Renal and metabolic effects of tempol in obese ZSF1 rats--distinct role for superoxide and hydrogen peroxide in diabetic renal injury.
Rafikova O; Salah EM; Tofovic SP
Metabolism; 2008 Oct; 57(10):1434-44. PubMed ID: 18803950
[TBL] [Abstract][Full Text] [Related]
38. Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling.
Kuo CW; Shen CJ; Tung YT; Chen HL; Chen YH; Chang WH; Cheng KC; Yang SH; Chen CM
Life Sci; 2015 Aug; 135():77-86. PubMed ID: 26006040
[TBL] [Abstract][Full Text] [Related]
39. Crocin improves renal function by declining Nox-4, IL-18, and p53 expression levels in an experimental model of diabetic nephropathy.
Yaribeygi H; Mohammadi MT; Rezaee R; Sahebkar A
J Cell Biochem; 2018 Jul; 119(7):6080-6093. PubMed ID: 29575259
[TBL] [Abstract][Full Text] [Related]
40. Tetramethylpyrazine alleviates diabetic nephropathy through the activation of Akt signalling pathway in rats.
Rai U; Kosuru R; Prakash S; Tiwari V; Singh S
Eur J Pharmacol; 2019 Dec; 865():172763. PubMed ID: 31682792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
